Kunming Longjin Pharmaceutical Co., Ltd. (SHE:002750)
0.5900
+0.0200 (3.51%)
Inactive · Last trade price on Jun 26, 2025
SHE:002750 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 44.67 | 65.16 | 85.8 | 121.15 | 698.35 | 253.71 | Upgrade |
Other Revenue | 1.32 | 1.32 | 0.82 | 1.81 | 4.17 | 0.32 | Upgrade |
45.99 | 66.48 | 86.62 | 122.97 | 702.52 | 254.03 | Upgrade | |
Revenue Growth (YoY) | -49.71% | -23.25% | -29.55% | -82.50% | 176.55% | -7.72% | Upgrade |
Cost of Revenue | 33.37 | 39.42 | 39.5 | 38.99 | 485.76 | 52.91 | Upgrade |
Gross Profit | 12.63 | 27.06 | 47.12 | 83.98 | 216.76 | 201.11 | Upgrade |
Selling, General & Admin | 54.09 | 68.65 | 95.25 | 109.13 | 199.62 | 185.16 | Upgrade |
Research & Development | 7.11 | 7.43 | 22.22 | 24.95 | 19.59 | 19.6 | Upgrade |
Other Operating Expenses | 2.83 | 2.86 | 3.22 | 3.55 | 5.77 | 5.08 | Upgrade |
Operating Expenses | 63.59 | 78.32 | 120.78 | 138.97 | 233.64 | 210.54 | Upgrade |
Operating Income | -50.96 | -51.26 | -73.66 | -55 | -16.88 | -9.43 | Upgrade |
Interest Expense | -0.26 | -0.24 | - | - | -0.47 | - | Upgrade |
Interest & Investment Income | 7.62 | 7.97 | 6.2 | 8.58 | 9.9 | 10.19 | Upgrade |
Other Non Operating Income (Expenses) | 0.01 | 0.07 | -0.05 | 0.8 | -2.77 | 0.15 | Upgrade |
EBT Excluding Unusual Items | -43.58 | -43.46 | -67.51 | -45.62 | -10.22 | 0.91 | Upgrade |
Impairment of Goodwill | -2.64 | -2.64 | -7.45 | -1.9 | -0.16 | - | Upgrade |
Gain (Loss) on Sale of Investments | 0.75 | 0.59 | -4.46 | -10.57 | -0.2 | -3.68 | Upgrade |
Gain (Loss) on Sale of Assets | 0.02 | 0.02 | - | -0.18 | 0.19 | -0.02 | Upgrade |
Asset Writedown | -5.9 | -5.9 | -8.68 | -4.1 | -0.34 | -0.03 | Upgrade |
Other Unusual Items | 7.58 | 6.22 | 5.86 | -6.37 | 5.16 | 10.14 | Upgrade |
Pretax Income | -43.78 | -45.17 | -82.24 | -68.73 | -5.56 | 7.31 | Upgrade |
Income Tax Expense | 2.52 | 1.8 | 2.02 | 4.8 | 1.9 | -0.44 | Upgrade |
Earnings From Continuing Operations | -46.3 | -46.98 | -84.26 | -73.53 | -7.46 | 7.75 | Upgrade |
Minority Interest in Earnings | 5.27 | 5.53 | 13.32 | 17.41 | 10.55 | 4.06 | Upgrade |
Net Income | -41.03 | -41.44 | -70.94 | -56.12 | 3.09 | 11.81 | Upgrade |
Net Income to Common | -41.03 | -41.44 | -70.94 | -56.12 | 3.09 | 11.81 | Upgrade |
Net Income Growth | - | - | - | - | -73.81% | - | Upgrade |
Shares Outstanding (Basic) | 400 | 400 | 401 | 401 | 402 | 400 | Upgrade |
Shares Outstanding (Diluted) | 400 | 400 | 401 | 401 | 402 | 400 | Upgrade |
Shares Change (YoY) | -0.18% | -0.04% | 0.01% | -0.30% | 0.34% | -0.02% | Upgrade |
EPS (Basic) | -0.10 | -0.10 | -0.18 | -0.14 | 0.01 | 0.03 | Upgrade |
EPS (Diluted) | -0.10 | -0.10 | -0.18 | -0.14 | 0.01 | 0.03 | Upgrade |
EPS Growth | - | - | - | - | -73.90% | - | Upgrade |
Free Cash Flow | -58.51 | -44.93 | -54.93 | -39.66 | -25.16 | -30.39 | Upgrade |
Free Cash Flow Per Share | -0.15 | -0.11 | -0.14 | -0.10 | -0.06 | -0.08 | Upgrade |
Gross Margin | 27.46% | 40.71% | 54.40% | 68.29% | 30.86% | 79.17% | Upgrade |
Operating Margin | -110.80% | -77.11% | -85.04% | -44.73% | -2.40% | -3.71% | Upgrade |
Profit Margin | -89.21% | -62.34% | -81.90% | -45.64% | 0.44% | 4.65% | Upgrade |
Free Cash Flow Margin | -127.21% | -67.59% | -63.41% | -32.26% | -3.58% | -11.96% | Upgrade |
EBITDA | -38.11 | -34.9 | -43.26 | -25.4 | 13.77 | 18.83 | Upgrade |
EBITDA Margin | -82.87% | -52.50% | -49.94% | -20.65% | 1.96% | 7.41% | Upgrade |
D&A For EBITDA | 12.85 | 16.36 | 30.4 | 29.6 | 30.65 | 28.26 | Upgrade |
EBIT | -50.96 | -51.26 | -73.66 | -55 | -16.88 | -9.43 | Upgrade |
EBIT Margin | -110.80% | -77.11% | -85.04% | -44.73% | -2.40% | -3.71% | Upgrade |
Revenue as Reported | 45.99 | 66.48 | 86.62 | 122.97 | 702.52 | 254.03 | Upgrade |
Advertising Expenses | - | 0.01 | 0.18 | 0.21 | 0.29 | 0.01 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.